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Identification of PEG-precipitable serum factor associated
with malignant lymphoma as C-reactive protein
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Inn Fields, and tDepartment ofMedical Oncology, Charing Cross Hospital, London.
A recent report described a serum factor with
potential as a monitor of malignant lymphoma
(Begent et al., 1980). The protein could be
precipitated from serum by low concentrations of
polyethylene glycol 6000 (PEG) and had a mol. wt.
of - 23 K daltons by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE).
While these preliminary studies showed a strong
association of the factor with active disease in
Hodgkin's disease and non-Hodgkin lymphoma, it
was also demonstrated in some patients with non-
lymphoreticular malignancy and in one individual
with herpes zoster. This distribution suggested that
the component detected could be one of the plasma
proteins generally referred to as "acute-phase
reactants" whose concentration is significantly
increased in the acute phase of inflammation (Koj,
1974) as well as in more chronic disease states
(Pepys, 1981).
Further investigations, reported here, support this
view since we have identified this entity as C-
reactive protein (CRP). In addition, the relative
insolubility of CRP in low concentrations of PEG
appears to be dependent on that proportion of
CRP which is complexed in serum.
Sera, obtained from patients attending the
Department of Medical Oncology at the Charing
Cross Hospital for treatment of Hodgkin's disease
or non-Hodgkin lymphoma or from healthy
laboratory and nursing staff, were stored at -70°C
prior to testing. Whole serum was fractionated by
gel filtration on a Sephacryl S-200 (Pharmacia)
column (70 x 2.5cm) in phosphate-buffered saline
(PBS), 0.15M. pH 7.4 at a flow rate of 30mlh-'.
Eluate fractions (2.5ml) were collected, precipitated
in 10% trichloroacetic acid and examined by SDS-
PAGE under non-reducing conditions. SDS-PAGE
and PEG precipitation were performed as described
previously (Begent et al., 1980). PEG precipitates
were solubilised in SDS sample buffer (2% SDS,
10% glycerol in 0.1 M Tris, pH 6.8) for SDS-PAGE
or barbital buffer, 0.075m, pH 8.6 containing
0.01 M EDTA for quantitation of CRP by rocket
immunoelectrophoresis (Laurell, 1972).
Immunoadsorption experiments were performed
according to a modification of the method of
Kessler (1975). Following precipitation of 0.1 ml
serum at a final concentration of 3.5% PEG, pellets
were dissolved in 0.1 ml of 0.05% NP-40 in NaCl-
EDTA-Tris (150mm NaCl, 5mm EDTA, 50mm
Tris) buffer, pH 7.4. Two hundred microlitres of
10% (v/v) S. aureus (Cowan I strain) organisms,
precoated by incubation with 50til rabbit anti-CRP
or anti-human serum albumin (Dako)
immunoglobulin were washed and pelleted and used
to adsorb solubilised PEG precipitates. Incubation
was for 30min at room temperature with constant
resuspension, followed by centrifugation and
collection of supernatants. Unbound proteins were
examined by SDS-PAGE.
Electrophoretic transfer of proteins from SDS-
polyacrylamide gels to nitrocellulose paper and
immunodetection were carried out as described by
Towbin et al. (1979) except for the following
modifications: Blots were soaked in 0.6% gelatin
(Fisons) in PBS to saturate additional binding sites,
washed and incubated with rabbit anti-CRP or
control antisera at a final dilution of 1/100 in PBS
containing 0.05% Tween 20 (Sigma) for 1 h at room
temperature. After washing with PBS/Tween 20,
'25I-protein A (Pharmacia), labelled by a modified
version of the chloramine T method (Hudson &
Hay, 1980) to a specific activity of 5-10pCi g-1,
was used to detect bound antibody. Incubation was
for 1 h at toom temperature in PBS/Tween 20
containing 5 x i05 cpmml-1 of radio-iodinated
protein A.
Gel filtration of whole serum on Sephacryl S-200
followed by SDS-PAGE analysis of eluate fractions
showed that a band with the same mobility as the
factor could be recovered from fractions eluting
between IgG and albumin (Figure 1). This indicated
that the 23 K mol. wt. protein was present in
serum in complexed form or as the subunit of a
heavier molecule. In addition, it was possible that
some dissociation may have occurred during gel
filtration since a protein of - 100K daltons would
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Figure 1 SDS-PAGE of S-200 fractionated serum from a patient with non-Hodgkin lymphoma. PEG
precipitate of normal serum, Track A and lymphoma serum, Track B. A band of the approximate mol. wt. of
the factor (23 K daltons) was recovered at maximum concentration in fraction 71.
not normally be precipitated by low concentrations
of PEG (Creighton et al., 1973). The possibility that
the serum factor was the acute phase reactant CRP
was investigated directly as the data were consistent
with the known mol. wt. and subunit structure of
CRP (Gotschlich & Edelman, 1965).
Purified human CRP (a gift from Dr. M.B. Pepys,
Hammersmith Hospital) co-migrated with the
protein on SDS-PAGE under non-reducing
conditions and after reduction with 2-
mercaptoethanol (Figure 2). Furthermore, the
protein was specifically removed from solubilised
3.5% PEG precipitates by adsorption with S. aureus
precoated with rabbit anti-CRP antiserum and
could be demonstrated directly following
electrophoretic blotting of SDS-polyacrylamide gels
by overlay with anti-CRP immunoglobulin (Figure
2).
Quantitation of CRP by rocket
immunoelectrophoresis in material precipitated
from pretreatment sera by PEG showed that values
of between 33 and 90% of whole serum levels were
precipitable. The solubility of this fraction in 3.5%
PEG increased when EDTA (final concentration,
0.01 M) was included in the precipitation step. The
proportion of CRP precipitating was independent of
the levels recorded in both serum and material
precipitated in the absence of EDTA (Figure 3).
Estimations of the ratio of total-to-precipitable
CRP in malignant lymphoma showed that this can
fluctuate during the course of disease but did not
provide a better discriminant of tumour status than
whole serum CRP levels (data not shown).
We conclude that the serum factor in malignant
lymphoma, described in a previous publication
(Begent et al., 1980), is CRP and that its detection
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Figure 2 SDS-PAGE under non-reducing conditions of 3.5% PEG precipitate of Hodgkin's disease serum
before and after immunoadsorption (Tracks A-D) and immunodetection of CRP in same material after
electrophoretic transfer of reduced samples (Tracks E-J). Track A, CRP. Track B, unadsorbed PEG
precipitate. Track C, after adsorption with anti-CRP and Track D, with anti-human serum albumin. Stained
blot (Tracks E-G) and autoradiogram of identical blot after probing with anti-CRP immunoglobulin (Tracks
H-J). Track E and H, CRP. Track F and I, normal serum PEG precipitate. Tracks G and J, PEG precipitate
of serum from Hodgkin's disease.
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Figure 3 Representative examples of levels of CRP in
whole sera (open columns) in relation to levels in 3.5%
PEG precipitates in the presence (solid columns) and
absence (hatched columns) of 0.01 M EDTA.
in material precipitated by PEG was a consequence
of both cation-dependent and -independent
complexing of CRP.
Several early studies provide some evidence for
the complexing of CRP in serum (Wood, 1963;
Hokama et al., 1967) and more recently, calcium-
dependent and -independent binding of CRP to a
wide range of autogenous products have been
demonstrated in vitro (Pepys, 1981). In addition,
once complexed, CRP has been shown to exhibit a
number of functional properties in vitro (Fiedel &
Gewurz, 1976; Kindmark, 1971) of which the ability
to activate the classical complement pathway is the
best documented (Kaplan & Volanakis, 1974; Claus
et al., 1977). C-reactive protein is a mediator in the
lysis of human erythrocytes sensitised by the brown
recluse spider venom (Hufford & Morgan, 1981).
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There is, however, no other evidence to connect
raised CRP levels in vivo or the predominantly
cation-dependent, loosely-associated serum
complexes described here and by others (Wood,
1963; Hokama et al., 1967) with the biological
activities described in vitro.
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